Completed Studies
- Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network (CTN-0073)
- Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance across Health Systems (CTN-0072)
- Electronic Health Records Data Elements Research (EHR-DARE) (CTN-0071)
- Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot (CTN-0070)
- Opioid Use Disorder in the Emergency Department (CTN-0069)
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder (CTN-0068)
- Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES); Scale-Up (CTN-0067)
- Opioid Use Disorders in Primary Care Settings: Linking EHRs with PDMP and National Death Index Data Systems (CTN-0066)
- Evaluation of Drug Screening Implementation in Primary Care (CTN-0065)
- Linkage to Hepatitis C Virus Care among HIV/HCV Co-infected Substance Users (CTN-0064)
- Gender Differences in the Interrelationships between Sexual Abuse, Risky Sexual Behavior, and Anxiety/Depression in Treatment Efficacy and Drug Use over Time among Individuals with Substance Use Disorders (CTN-0063)
- A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements into the Electronic Health Record in Large Primary Care Settings (CTN-0062)
- Kaiser Virtual Data Warehouse - Prescription Opioid Users (CTN-0061)
- Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse Brief screen/assessment tool (TAPS Tool) (CTN-0059)
- Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC): An add-on project to “Duke University CMS Innovation Award Southeastern Diabetes Initiative” (CTN-0057)
- Testing and Linkage to HIV Care in China: a Cluster Randomized Trial (CTN-0056)
- Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES) (CTN-0055)
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT) (CTN-0054)
- Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT) (CTN-0053)
- A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) (CTN-0052)
- Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) (CTN-0051)
- The START Follow-Up Study (CTN-0050)
- Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users (CTN-0049)
- Cocaine Use Reduction with Buprenorphine (CURB) (CTN-0048)
- Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) (CTN-0047)
- Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes (CTN-0046)
- Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders (CTN-0044)
- Stimulant Reduction Intervention using Dosed Exercise (CTN-0037)
- HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S. (CTN-0032)
- An Evaluation of Neurocognitive Function, Oxidative Damage, and their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers (CTN -0031-A-1)
- Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement (CTN-0031)
- Prescription Opioid Addiction Treatment Study (POATS) (CTN-0030)
- A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD) (CTN-0029)
- Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in Adolescents with Substance Use Disorders (CTN-0028)
- Starting Treatment with Agonist Replacement Therapies (START) Study (CTN-0027)
- Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse (CTN-0021)
- Job-Seekers Training for Patients with Drug Dependence (CTN-0020)
- Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment (CTN-0019)
- Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment (CTN-0018)
- HIV and HCV Intervention in Drug Treatment Settings (CTN-0017)
- Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment (CTN-0016)
- Women's Treatment for Trauma and Substance Use Disorders (CTN-0015)
- Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abusers (CTN-0014)
- Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users (CTN-0013)
- Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs (CTN-0012)
- A Feasibility Study of a Telephone Enhancement Procedure (TELE) To Improve Participation in Continuing Care Activities (CTN-0011)
- Buprenorphine/Naloxone (Bup/Nx) Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults (CTN-0010)
- Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs (CTN-0009)
- A Baseline for Investigating Diffusion of Innovation (CTN-0008)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics (CTN-0007)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics (CTN-0006)
- Motivational Interviewing (MI) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0005)
- MET (Motivational Enhancement Treatment) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0004)
- Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules (CTN-0003)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Outpatient Opiate Detoxification (CTN-0002)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Inpatient Opiate Detoxification (CTN-0001)